Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression

Neurobiology of Disease

Volumn 57, Issue , 2013, Pages 28-37

  Ota, Kristie T ^a   Duman, Ronald S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Antidepressants; Early life stress; Exercise; Major depressive disorder; Omega 3 fatty acids; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3; LITHIUM SALT; METABOTROPIC RECEPTOR 2 ANTAGONIST; METABOTROPIC RECEPTOR 3 ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; MOOD STABILIZER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROGENIC DIFFERENTIATION FACTOR; NEUROTROPHIC FACTOR; OMEGA 3 FATTY ACID; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLELE; ANTIDEPRESSANT ACTIVITY; CELL STRUCTURE; CHRONIC STRESS; DIET RESTRICTION; DIET THERAPY; EARLY LIFE STRESS; ENVIRONMENTAL FACTOR; EXERCISE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LONG TERM POTENTIATION; MAJOR DEPRESSION; MATERNAL CARE; MENTAL STRESS; MOOD DISORDER; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RUNNING; SIGNAL TRANSDUCTION; TREATMENT DURATION;

DEPRESSIVE DISORDER, MAJOR; EXERCISE THERAPY; FATTY ACIDS, OMEGA-3; HUMANS; NERVE GROWTH FACTORS; NEUROGENESIS; NEURONAL PLASTICITY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84879779725     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.05.022     Document Type: Review

References (210)

1. Adlard P.A., Cotman C.W. Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 2004, 124:985-992.
2. Alder J., et al. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 2003, 23:10800-10808.
3. Anisman H., et al. Do early-life events permanently alter behavioral and hormonal responses to stressors?. Int. J. Dev. Neurosci. 1998, 16:149-164.
4. Autry A.E., et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 1-7.
5. Babyak M., et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom. Med. 2000, 62:633-638.
6. Baj G., et al. Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 2012, 37:1600-1611.
7. Barnes P.M., et al. Complementary and alternative medicine use among adults and children: United States, 2007. Natl. Health Stat. Rep. 2008, 1-23.
8. Belke T.W., Wagner J.P. The reinforcing property and the rewarding aftereffect of wheel running in rats: a combination of two paradigms. Behav. Processes 2005, 68:165-172.
9. Bergström A., et al. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res. 2008, 1196:41-52.
10. Berman R.M., et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47:351-354.
11. Beurel E., et al. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol. Psychiatry 2011, 16:1068-1070.
12. Bjørnebekk A., et al. The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int. J. Neuropsychopharmacol. 2005, 8:357-368.
13. Bocchio-Chiavetto L., et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J. Biol. Psychiatry 2010, 11:763-773.
14. Boldrini M., et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009, 34:2376-2389.
15. Bourre J.M., et al. Essentiality of omega 3 fatty acids for brain structure and function. World Rev. Nutr. Diet. 1991, 66:103-117.
16. Bradley S.R., et al. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling. Pharmacol. Biochem. Behav. 2012, 101:35-40.
17. Bremner J.D., et al. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157:115-118.
18. Brunoni A.R., et al. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
19. Bueller J.A., et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 2006, 59:812-815.
20. Calderon F., Kim H.-Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J. Neurochem. 2004, 90:979-988.
21. Caldji C., et al. The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. Neuropsychopharmacology 2000, 22:219-229.
22. Campbell S., et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 2004, 161:598-607.
23. Carlezon W.A., et al. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol. Psychiatry 2005, 57:343-350.
24. Caspi A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
25. Castrén E., et al. Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 2007, 7:18-21.
26. Chandler-Laney P.C., et al. A history of caloric restriction induces neurochemical and behavioral changes in rats consistent with models of depression. Pharmacol. Biochem. Behav. 2007, 87:104-114.
27. Charney D.S., Manji H.K. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci. STKE 2004, 2004:re5.
28. Chen M.J., Russo-Neustadt A.A. Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent. Hippocampus 2009, 19:962-972.
29. Chen B., et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
30. Chen Z.-Y., et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 2004, 24:4401-4411.
31. Chen Z.-Y., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
32. Chiaruttini C., et al. Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16481-16486.
33. Conklin S.M., et al. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci. Lett. 2007, 421:209-212.
34. Dagai L., et al. Docosahexaenoic acid significantly stimulates immediate early response genes and neurite outgrowth. Neurochem. Res. 2009, 34:867-875.
35. David D.J., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
36. DeMar J.C., et al. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 2006, 47:172-180.
37. Dishman R.K., et al. Activity wheel running reduces escape latency and alters brain monoamine levels after footshock. Brain Res. Bull. 1997, 42:399-406.
38. Drevets W.C., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997, 386:824-827.
39. Drew M.R., Hen R. Adult hippocampal neurogenesis as target for the treatment of depression. CNS Neurol. Disord. Drug Targets 2007, 6:205-218.
40. Droste S.K., et al. Voluntary exercise impacts on the rat hypothalamic-pituitary-adrenocortical axis mainly at the adrenal level. Neuroendocrinology 2007, 86:26-37.
41. Duan W., et al. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J. Neurochem. 2001, 76:619-626.
42. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 2004, 56:140-145.
43. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004, 5:11-25.
44. Duman R.S. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol. Aging 2005, 26(Suppl. 1):88-93.
45. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
46. Duman R.S., Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 2012, 35:47-56.
47. Duman C.H., et al. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 2007, 61:661-670.
48. Duman C.H., et al. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res. 2008, 1199:148-158.
49. Duman C.H., et al. Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise. Behav. Brain Res. 2009, 198:366-371.
50. Duman R.S., et al. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2011, 37:47-56.
51. Dunn A.L., et al. Exercise treatment for depression: efficacy and dose response. Am. J. Prev. Med. 2005, 28:1-8.
52. Duric V., et al. A negative regulator of MAP kinase causes depressive behavior. Nat. Med. 2010, 16:1328-1332.
53. Dwivedi Y., et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:804-815.
54. Dwivedi Y., et al. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol. Psychiatry 2006, 11:86-98.
55. Dwivedi Y., et al. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology 2007, 32:2338-2350.
56. Dwyer J.M., et al. mTOR activation is required for the antidepressant effects of mGluR2/3 blockade. Int. J. Neuropsychopharmacol. 2011, 1-6.
57. Egan M.F., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
58. Eley T.C., et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol. Psychiatry 2004, 9:908-915.
59. Elzinga B.M., et al. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berl) 2011, 214:319-328.
60. Erickson K.I., et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3017-3022.
61. Fabel K., et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur. J. Neurosci. 2003, 18:2803-2812.
62. Farmer J., et al. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004, 124:71-79.
63. Felitti V.J., et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) study. Am. J. Prev. Med. 1998, 14:245-258.
64. Ferraz A.C., et al. Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behav. Brain Res. 2011, 219:116-122.
65. Fournier N.M., Duman R.S. Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depression. Behav. Brain Res. 2011, 227:440-449.
66. Freeman M.P. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:291-297.
67. Gatt J.M., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol. Psychiatry 2009, 14:681-695.
68. George E.D., et al. Maternal separation with early weaning: a novel mouse model of early life neglect. BMC Neurosci. 2010, 11:123.
69. Gertsik L., et al. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J. Clin. Psychopharmacol. 2012, 32:61-64.
70. Gervasoni N., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005, 51:234-238.
71. Gorzalka B.B., Hill M.N. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1575-1585.
72. Grabe H.J., et al. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36:264-270.
73. Greenwood B.N., et al. Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J. Neurosci. 2003, 23:2889-2898.
74. Greenwood B.N., et al. The consequences of uncontrollable stress are sensitive to duration of prior wheel running. Brain Res. 2005, 1033:164-178.
75. Greer P.L., Greenberg M.E. From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 2008, 59:846-860.
76. Grenyer B.F.S., et al. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1393-1396.
77. Hahm S., et al. Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 1999, 23:537-548.
78. Hakkarainen R., et al. Is low dietary intake of omega-3 fatty acids associated with depression?. Am. J. Psychiatry 2004, 161:567-569.
79. Hariri A.R., et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 2003, 23:6690-6694.
80. Heim C., Binder E.B. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp. Neurol. 2011, 233:102-111.
81. Heim C., Nemeroff C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry 1999, 46:1509-1522.
82. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 2001, 49:1023-1039.
83. Heine V.M., et al. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur. J. Neurosci. 2005, 21:1304-1314.
84. Herring M.P., et al. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch. Intern. Med. 2012, 172:101-111.
85. Hibbeln J.R. Fish consumption and major depression. Lancet 1998, 351:1213.
86. Hill M.N., et al. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus 2010, 20:513-523.
87. Hoeffer C.A., Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 2010, 33:67-75.
88. Huang S.-Y., et al. Omega-3 fatty acids on the forced-swimming test. J. Psychiatr. Res. 2008, 42:58-63.
89. Hulshof H.J., et al. Maternal separation decreases adult hippocampal cell proliferation and impairs cognitive performance but has little effect on stress sensitivity and anxiety in adult Wistar rats. Behav. Brain Res. 2011, 216:552-560.
90. Hunsberger J.G., et al. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13:1476-1482.
91. Iversen I.H. Techniques for establishing schedules with wheel running as reinforcement in rats. J. Exp. Anal. Behav. 1993, 60:219-238.
92. Izquierdo A., et al. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 2006, 26:5733-5738.
93. Jahng J.W., et al. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res. 2007, 1150:100-107.
94. James M.J., Cleland L.G. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin. Arthritis Rheum. 1997, 27:85-97.
95. Jernigan C.S., et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1774-1779.
96. Jourdi H., et al. BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 2009, 56:876-885.
97. Karege F., et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 2005, 57:1068-1072.
98. Kaufman J., et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17316-17321.
99. Kaufman J., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol. Psychiatry 2006, 59:673-680.
100. Kendler K.S. "A gene for. .": the nature of gene action in psychiatric disorders. Am. J. Psychiatry 2005, 162:1243-1252.
101. Kessler R.C., et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
102. Kiuchi T., et al. Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice. Neuroscience 2012, 207:208-217.
103. Klein A.B., et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 2011, 14:347-353.
104. Koike H., et al. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuropharmacology 2011, 61:1419-1423.
105. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
106. Lafenêtre P., et al. Exercise can rescue recognition memory impairment in a model with reduced adult hippocampal neurogenesis. Front. Behav. Neurosci. 2010, 3:34.
107. Lambrechts D., et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 2003, 34:383-394.
108. Lee J., et al. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 2002, 82:1367-1375.
109. Lee J., et al. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J. Neurochem. 2002, 80:539-547.
110. Lee J.-H., et al. Depressive behaviors and decreased expression of serotonin reuptake transporter in rats that experienced neonatal maternal separation. Neurosci. Res. 2007, 58:32-39.
111. Lespérance F., et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J. Clin. Psychiatry 2011, 72:1054-1062.
112. Li Y., et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008, 59:399-412.
113. Li N., et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
114. Li N., et al. Glutamate N-methyl-d-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 2011, 69:754-761.
115. Liebrenz M., et al. Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med. Wkly. 2007, 137:234-236.
116. Liu D., et al. Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat. Neurosci. 2000, 3:799-806.
117. Liu R.-J., et al. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol. Psychiatry 2011, 71:996-1005.
118. Llorens-Martín M., et al. Exercise modulates insulin-like growth factor 1-dependent and -independent effects on adult hippocampal neurogenesis and behaviour. Mol. Cell. Neurosci. 2010, 44:109-117.
119. Magariños A.M., et al. Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus 2011, 21:253-264.
120. Maier S.F., Watkins L.R. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 2005, 29:829-841.
121. Makatsori A., et al. Voluntary wheel running modulates glutamate receptor subunit gene expression and stress hormone release in Lewis rats. Psychoneuroendocrinology 2003, 28:702-714.
122. Marangell L.B., et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 2003, 160:996-998.
123. Martinowich K., et al. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007, 10:1089-1093.
124. Martins J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 2009, 28:525-542.
125. Mattson M.P. Energy intake, meal frequency, and health: a neurobiological perspective. Annu. Rev. Nutr. 2005, 25:237-260.
126. Mattson M.P., et al. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
127. Mattson M.P., et al. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res. Rev. 2004, 3:445-464.
128. McAllister A.K. Spatially restricted actions of BDNF. Neuron 2002, 36:549-550.
129. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 1999, 22:105-122.
130. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
131. McKinnon M.C., et al. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J. Psychiatry Neurosci. 2009, 34:41-54.
132. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 2001, 24:1161-1192.
133. Mirescu C., et al. Early life experience alters response of adult neurogenesis to stress. Nat. Neurosci. 2004, 7:841-846.
134. Mischoulon D., Fava M. Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatr. Clin. North Am. 2000, 23:785-794.
135. Moghaddam B., et al. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17:2921-2927.
136. Monteggia L.M. Elucidating the role of brain-derived neurotrophic factor in the brain. Am. J. Psychiatry 2007, 164:1790.
137. Monteggia L.M., et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10827-10832.
138. Mullen P.E., et al. The long-term impact of the physical, emotional, and sexual abuse of children: a community study. Child Abuse Negl. 1996, 20:7-21.
139. Murakami S., et al. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci. Res. 2005, 53:129-139.
140. Naliwaiko K., et al. Effects of fish oil on the central nervous system: a new potential antidepressant?. Nutr. Neurosci. 2004, 7:91-99.
141. Nederhof E., et al. Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biol. Psychiatry 2010, 68:209-212.
142. Nemets B., et al. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am. J. Psychiatry 2002, 159:477-479.
143. Nestler E.J., et al. Preclinical models: status of basic research in depression. Biol. Psychiatry 2002, 52:503-528.
144. Nibuya M., et al. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
145. Nibuya M., et al. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996, 16:2365-2372.
146. Pezawas L., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J. Neurosci. 2004, 24:10099-10102.
147. Radley J.J., et al. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004, 125:1-6.
148. Radley J.J., et al. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb. Cortex 2006, 16:313-320.
149. Rajkowska G., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry 1999, 45:1085-1098.
150. Rao J.S., et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 2007, 12:36-46.
151. Redila V.A., Christie B.R. Exercise-induced changes in dendritic structure and complexity in the adult hippocampal dentate gyrus. Neuroscience 2006, 137:1299-1307.
152. Rees A.-M., et al. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust. N. Z. J. Psychiatry 2008, 42:199-205.
153. Risch N., et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009, 301:2462-2471.
154. Roceri M., et al. Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol. Psychiatry 2004, 55:708-714.
155. Rocha Araujo D.M., et al. What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression?. Expert Rev. Neurother. 2010, 10:1117-1129.
156. Roozendaal B., et al. Stress, memory and the amygdala. Nat. Rev. Neurosci. 2009, 10:423-433.
157. Roth G.S., et al. Effects of reduced energy intake on the biology of aging: the primate model. Eur. J. Clin. Nutr. 2000, 54(Suppl. 3):S15-S20.
158. Russo-Neustadt A., et al. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999, 21:679-682.
159. Russo-Neustadt A.A., et al. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 2000, 101:305-312.
160. Sacher J., et al. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J. Affect. Disord. 2011, 140:142-148.
161. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007, 10:1110-1115.
162. Sairanen M., et al. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25:1089-1094.
163. Samuels B.A., Hen R. Neurogenesis and affective disorders. Eur. J. Neurosci. 2011, 33:1152-1159.
164. Sanacora G. Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of smoke but is there fire?. Biol. Psychiatry 2010, 67:397-398.
165. Santarelli L., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
166. Sartori C.R., et al. The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA. Neuroscience 2011, 180:9-18.
167. Schmidt H.D., Duman R.S. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 2010, 35:2378-2391.
168. Schmidt H.D., et al. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011, 36:2375-2394.
169. Seligman M.E., Beagley G. Learned helplessness in the rat. J. Comp. Physiol. Psychol. 1975, 88:534-541.
170. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936, 138.
171. Sen S., et al. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
172. Shansky R.M., et al. Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific. Cereb. Cortex 2009, 19:2479-2484.
173. Sheline Y.I., et al. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3908-3913.
174. Sheline Y.I., et al. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160:1516-1518.
175. Shimizu E., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54:70-75.
176. Shirayama Y., et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
177. Siuciak J.A., et al. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 1997, 56:131-137.
178. Slipczuk L., et al. BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS One 2009, 4:e6007.
179. Snyder J.S., et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
180. Sousa N., et al. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000, 97:253-266.
181. Sparling P.B., et al. Exercise activates the endocannabinoid system. Neuroreport 2003, 14:2209-2211.
182. Stockmeier C.A., et al. Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatry 2004, 56:640-650.
183. Stranahan A.M., et al. Running induces widespread structural alterations in the hippocampus and entorhinal cortex. Hippocampus 2007, 17:1017-1022.
184. Stranahan A.M., et al. Central mechanisms of HPA axis regulation by voluntary exercise. Neuromolecular Med. 2008, 10:118-127.
185. Su K.-P., et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 2003, 13:267-271.
186. Szeszko P.R., et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 2005, 10:631-636.
187. Takei N., et al. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 2004, 24:9760-9769.
188. Taliaz D., et al. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol. Psychiatry 2010, 15:80-92.
189. Tang K., et al. Exercise-induced VEGF transcriptional activation in brain, lung and skeletal muscle. Respir. Physiol. Neurobiol. 2010, 170:16-22.
190. Thakker-Varia S., et al. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 2007, 27:12156-12167.
191. Trejo J.L., et al. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 2001, 21:1628-1634.
192. Trejo J.L., et al. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol. Cell. Neurosci. 2008, 37:402-411.
193. Uher R., et al. Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. J. Affect. Disord. 2011, 135:56-65.
194. van Praag H., et al. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2:266-270.
195. Venna V.R., et al. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34:199-211.
196. Verhagen M., et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol. Psychiatry 2010, 15:260-271.
197. Vermetten E., et al. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 2003, 54:693-702.
198. Viikki M., et al. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci. Lett. 2010, 477:105-108.
199. Vines A., et al. The role of 5-HT(1A) receptors in fish oil-mediated increased BDNF expression in the rat hippocampus and cortex: a possible antidepressant mechanism. Neuropharmacology 2011, 62:184-191.
200. Voleti B., Duman R.S. The roles of neurotrophic factor and Wnt signaling in depression. Clin. Pharmacol. Ther. 2011, 91:333-338.
201. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4647-4652.
202. Wei L., et al. Early life stress increases anxiety-like behavior in Balbc mice despite a compensatory increase in levels of postnatal maternal care. Horm. Behav. 2010, 57:396-404.
203. Weindruch R.H., et al. Influence of controlled dietary restriction on immunologic function and aging. Fed. Proc. 1979, 38:2007-2016.
204. Wichers M., et al. The BDNF Val(66)Met×5-HTTLPR×child adversity interaction and depressive symptoms: An attempt at replication. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:120-123.
205. Wilkinson P.O., Goodyer I.M. Childhood adversity and allostatic overload of the hypothalamic-pituitary-adrenal axis: a vulnerability model for depressive disorders. Dev. Psychopathol. 2011, 23:1017-1037.
206. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
207. Wolf S.A., et al. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun. Signal. 2010, 8:12.
208. Zarate C.A., et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
209. Zhao C., et al. Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus. J. Neurosci. 2006, 26:3-11.
210. Zheng H., et al. Beneficial effects of exercise and its molecular mechanisms on depression in rats. Behav. Brain Res. 2006, 168:47-55.